Under-representation of WHO Africa region in HBV clinical trials: The field advances, but in which direction?

The WHO Africa region bears a disproportionate burden of morbidity and mortality related to chronic Hepatitis B Virus (HBV), accounting for an estimated 70% of new infections worldwide. We investigated the extent to which HBV clinical trials (CT) represent populations in this region. Through analysi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lancet Gastroenterol Hepatol
Auteurs principaux: Delphin, Marion, Mohammed, Khadija Said, Downs, Louise O, Lumley, Sheila F, Waddilove, Elizabeth, Okanda, Dorcas, Aliyan, Nadia, Van Schalkwyk, Marije, Anderson, Motswedi, Ocama, Ponsiano, Maponga, Tongai, Torimiro, Judith, Iwuji, Collins, Ndung’u, Thumbi, Matthews, Philippa C, Taljaard, Jantjie
Format: Artigo
Langue:Inglês
Publié: 2024
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616036/
https://ncbi.nlm.nih.gov/pubmed/38367632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(23)00315-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires